Can patients with low-grade papillary bladder tumors be followed up with a cystoscopy interval of 6 months?
Alan So
Correspondence The Prostate Centre, 2660 Oak Street, Vancouver, BC V6H 3Z6, Canada
Email alan.so@ubc.ca
This article has no abstract so we have provided the first paragraph of the full text.
Although the majority of patients with bladder cancer present with non-muscle-invasive, low-grade papillary disease, the optimal treatment and follow-up of these patients is still unclear. Most commonly, current treatment consists of initial TUR, with or without immediate postoperative chemotherapy, followed by intensive cystoscopic surveillance, usually at 3-month intervals. Although these low-grade papillary tumors frequently recur, they rarely progress to a higher stage or grade. This 'benign' natural history, combined with the potential to identify low-grade tumors accurately with cystoscopy,1 has prompted the exploration of more conservative approaches in the management of these tumors.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.